3-Nitrophthalic acid
Based on 1 Customer Validation
3-Nitrophthalic acid (m-Nitrophthalic acid) is a nitro-substituted aromatic carboxylic acid that acts as a DPPH radical scavenger through hydrogen donation. 3-Nitrophthalic acid induces cellular oxidative stress and Apoptosis. 3-Nitrophthalic acid inhibits NRF2/HO-1 antioxidant signaling and impairs follicular development and ovulation. 3-Nitrophthalic acid can be used to construct functional MOF. 3-Nitrophthalic acid can be used in the study of premature ovarian insufficiency.
For research use only. We do not sell to patients.
- Purity : 99.95%
- CAS No.: 603-11-2
- Formula: C8H5NO6
- Molecular Weight:211.13
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
IC50 & Target
[3]|
HO-1 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR (female, 3-week-old, 10-12 g)[3]
-
Dosage:12.5 mg/kg
-
Administration:i.p.; once daily; 7 consecutive days, then day 8 to day 28
-
Result:Decreased the ovarian/body weight ratio compared with Control (Figure 1A,B).
Reduced the numbers of secondary, preantral, and antral follicles compared with Control (Figure 1C,D); primordial and primary follicle numbers did not differ among groups.
Following PMSG and hCG priming, the number of MII oocytes recovered from the NPA group was reduced compared with Control (Figure 1E,F).
The proportion of apoptotic granulosa cells in ovaries of the NPA group was greater than in Control (Figure 2A,B).
The proportion of PCNA-positive granulosa cells in the NPA group was lower than in Control (Figure 2C,D).
Peripheral blood estradiol and progesterone concentrations showed no differences between Control and NPA (Figure S2).
ROS levels were higher in the NPA group than in Control (Figure 4A).
MDA levels were elevated in the NPA group relative to Control (Figure 4B).
Immunostaining of ovarian sections showed weak HO-1 and SOD1 positive signals in the NPA group, whereas strong signals were observed in Control (Figure 4F).
Chemical Information
-
CAS No. 603-11-2
-
Appearance Solid
-
Molecular Weight 211.13
-
Formula C8H5NO6
-
Color White to off-white
-
SMILES
O=C(C1=CC=CC([N+]([O-])=O)=C1C(O)=O)O
-
Synonyms
m-Nitrophthalic acid; o-Nitrophthalic acid; 3-Nitrophthalic acid
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (473.64 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 5 mg/mL (23.68 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (23.68 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 5 mg/mL (23.68 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (615 KB)
- English - EN (615 KB)
- Français - FR (615 KB)
- Deutsch - DE (615 KB)
- Norwegian - NO (615 KB)
- Español - ES (615 KB)
- Swedish - SV (615 KB)
- Italian - IT (615 KB)
- Korean - KR (615 KB)
- Portuguese - PT (615 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 4.7364 mL | 23.6821 mL | 47.3642 mL | 118.4105 mL |
| 5 mM | 0.9473 mL | 4.7364 mL | 9.4728 mL | 23.6821 mL | |
| 10 mM | 0.4736 mL | 2.3682 mL | 4.7364 mL | 11.8410 mL | |
| 15 mM | 0.3158 mL | 1.5788 mL | 3.1576 mL | 7.8940 mL | |
| 20 mM | 0.2368 mL | 1.1841 mL | 2.3682 mL | 5.9205 mL | |
| DMSO | 25 mM | 0.1895 mL | 0.9473 mL | 1.8946 mL | 4.7364 mL |
| 30 mM | 0.1579 mL | 0.7894 mL | 1.5788 mL | 3.9470 mL | |
| 40 mM | 0.1184 mL | 0.5921 mL | 1.1841 mL | 2.9603 mL | |
| 50 mM | 0.0947 mL | 0.4736 mL | 0.9473 mL | 2.3682 mL | |
| 60 mM | 0.0789 mL | 0.3947 mL | 0.7894 mL | 1.9735 mL | |
| 80 mM | 0.0592 mL | 0.2960 mL | 0.5921 mL | 1.4801 mL | |
| 100 mM | 0.0474 mL | 0.2368 mL | 0.4736 mL | 1.1841 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
3-Nitrophthalic acid Related Classifications
HY-Y0251 Related Classifications
Powered by Bioz
Keywords
- 3-Nitrophthalic acid
- 603-11-2
- m-Nitrophthalic acid
- o-Nitrophthalic acid
- 3-Nitrophthalic acid
- MOFs
- Free Radical Scavengers
- Apoptosis
- Keap1-Nrf2
- Heme Oxygenase (HO)
- DPPH radical scavenger
- NRF2/HO-1 antioxidant signaling
- antibacterial activity
- apoptosis
- follicular development
- granulosa cell proliferation
- granulosa cells
- hydrogen donation
- ovulation
- oxidative stress
- Inhibitor
- inhibitor
- inhibit